Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Reversal of Neuromuscular Blockade and Postoperative Bleeding
NCT02939430Unknown
- Sponsor
- Mansoura University
- Start
- Nov 2016
- Primary completion
- Oct 2017
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Mansoura University. Primary endpoint: Activated Partial Thromboplastin Time. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02939430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02939430.